INDIANAPOLIS — An Indiana University School of Medicine researcher is working with the Mayo Clinic on a study looking at blood biomarkers and Alzheimer’s disease.
Dr. Jeffrey Dage's previous studies have demonstrated that blood levels of phosphorylated tau (P-tau) are indicators of the development of Alzheimer’s disease pathology in the brain.
READ: Study from Dr. Dage and others
Blood-based biomarkers are the goal in screening for and diagnosing Alzheimer’s disease in the population because they are less costly and invasive than imaging and a lumbar puncture, Dage and Dr. Michelle Mielke with the Mayo Clinic said.
The IU School of Medicine says there are multiple ways for Hoosiers to get involved in the research, including donating blood to the Indiana Biobank or by completing a participant referral form.
Additionally, some Indiana patients will receive new screenings for early detection of Alzheimer’s disease thanks to a pilot program.
The program provides a digital cognitive assessment tool to screen patients for Alzheimer’s and electronically check brain function. Currently, those screenings are not part of normal primary care visits.
The Core Cognitive Evaluation is completely iPad-based and combines a digital assessment with a lifestyle-based patient questionnaire to generate actionable insights for both providers and patients.
-
Businesses gear up for thousands of customers during Final Four weekend
IMPD searching for 25-year-old last seen on the southwest side
Vincent Eliyahu Smith, 25, is described as 6 feet tall, 185 pounds, with dark brown hair and brown eyes.
Town of Speedway takes steps to advance long-stalled Main Steet development
The town of Speedway announced Friday morning that it is ready to take action on the long-stalled hotel project on Main Street.
Mother, boyfriend charged with neglect resulting in death of 4-year-old
A mother and her boyfriend face charges of neglect after a 4-year-old boy with severe medical conditions died locked in a basement closet.
